Entegris Bolstered Operational Response to COVID-19
We are playing a supporting but crucial role in our customers’ efforts to develop and manufacture therapies for COVID-19 and are currently undergoing rapid scale up to meet commercial demand for the pipeline of potential successful candidates. You can be certain that we are committed to remaining a strong partner and as such, have dedicated ourselves to maintaining critical operations by relying on our business continuity plans and leveraging trusted supply partners.
Please submit this form if you would like additional detailed program information about Entegris’ COVID-19 programs for maintaining critical operations and accessibility or more about our participation in the BioPhorum and Rx-360 Joint Audit Model and enhanced Aramus 2D bag assembly validation guide improvements.
We are committed to helping you solve your most critical process challenges; you can be certain we will continue taking proactive steps to be a secure and reliable partner.